{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"47.8","upperLimit":"81.7","value":"62.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"}],"units":"Participants"}],"description":"Patients were evaluated for the development of chronic GVHD from 101 days post HSCT to last contact or documented evidence of the disease. The cumulative incidence of chronic GVHD was determined using competing risk analysis. Competing risks for GVHD were death and nonengraftment.","dispersionType":"95% Confidence Interval","groups":[{"description":"All patients were analyzed as a single population. Stratification by conditioning regimen was not done.","id":"OG000","title":"All Patients"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"2 year point estimate was provided.","title":"Cumulative Incidence of Chronic GVHD","type":"PRIMARY","unitOfMeasure":"Percentage of patients developing cGVHD"}